We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$34.8B
AUM Growth
-$269M
(-0.77%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
31.64%
Holding
2,717
New
60
Increased
1,190
Reduced
635
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$140M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$116M |
| 3 |
Walt Disney
DIS
|
+$95.4M |
| 4 |
Adobe
ADBE
|
+$90.7M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hubbell
HUBB
|
+$71M |
| 2 |
Micron Technology
MU
|
+$38.4M |
| 3 |
Alcon
ALC
|
+$37.4M |
| 4 |
United Rentals
URI
|
+$32.1M |
| 5 |
Cadence Design Systems
CDNS
|
+$31.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.85% |
| 2 | Financials | 18.08% |
| 3 | Healthcare | 12.65% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Industrials | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Codexis
CDXS
$161M
| $12.7K | ﹤0.01% |
4,726
+1,729
| +58% | +$6.7K |
|
2502
GlobalFoundries
GFS
$27.5B
| $12.6K | ﹤0.01% |
342
| – | – |
|
2503
argenx
ARGX
$54.2B
| $12.4K | ﹤0.01% |
+21
| New | +$13.3K |
|
2504
Theravance Biopharma
TBPH
$876M
| $12.3K | ﹤0.01% |
1,382
-15,596
| -92% | -$145K |
|
2505
Pliant Therapeutics
PLRX
$64.4M
| $12.1K | ﹤0.01% |
8,994
+964
| +12% | +$5.85K |
|
|
LENZ
2506
LENZ Therapeutics
LENZ
$168M
| $11.8K | ﹤0.01% |
+460
| New | +$11.3K |
|
2507
Inhibrx
INBX
$1.37B
| $11.5K | ﹤0.01% |
824
+706
| +598% | +$9.59K |
|
|
LKFT
2508
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
| $11.4K | ﹤0.01% |
+455
| New | +$11.5K |
|
2509
Omeros
OMER
$986M
| $11.2K | ﹤0.01% |
+1,358
| New | +$12K |
|
2510
Amylyx Pharmaceuticals
AMLX
$2.53B
| $11.2K | ﹤0.01% |
+3,152
| New | +$11.2K |
|
2511
Regenxbio
RGNX
$688M
| $11.1K | ﹤0.01% |
1,553
-15,108
| -91% | -$112K |
|
2512
AstraZeneca
AZN
$251B
| $11K | ﹤0.01% |
75
| – | – |
|
2513
Zevra Therapeutics
ZVRA
$682M
| $11K | ﹤0.01% |
+1,464
| New | +$11.6K |
|
|
CNTA
2514
DELISTED
Centessa Pharmaceuticals
CNTA
| $10.9K | ﹤0.01% |
755
-1,058
| -58% | -$17.3K |
|
2515
Limoneira
LMNR
$249M
| $10.1K | ﹤0.01% |
571
+84
| +17% | +$1.83K |
|
2516
Alvotech
ALVO
$1.28B
| $9.93K | ﹤0.01% |
+1,027
| New | +$12.5K |
|
2517
Cartesian Therapeutics
RNAC
$265M
| $9.38K | ﹤0.01% |
+712
| New | +$12.7K |
|
2518
AbCellera Biologics
ABCL
$2.85B
| $9.38K | ﹤0.01% |
+4,205
| New | +$12.1K |
|
2519
MaxCyte
MXCT
$130M
| $8.96K | ﹤0.01% |
3,283
+348
| +12% | +$1.37K |
|
|
ESPR
2520
DELISTED
Esperion Therapeutics
ESPR
| $8.76K | ﹤0.01% |
+6,082
| New | +$11.2K |
|
2521
Monte Rosa Therapeutics
GLUE
$1.35B
| $8.6K | ﹤0.01% |
+1,853
| New | +$11.4K |
|
2522
ArriVent BioPharma
AVBP
$1.44B
| $8.45K | ﹤0.01% |
+457
| New | +$11.2K |
|
2523
Design Therapeutics
DSGN
$897M
| $8.36K | ﹤0.01% |
+2,165
| New | +$10.3K |
|
2524
Alpha Teknova
TKNO
$361M
| $8.34K | ﹤0.01% |
+1,607
| New | +$11.9K |
|
|
MESO
2525
Mesoblast
MESO
$2.16B
| $7.9K | ﹤0.01% |
+633
| New | +$10.4K |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q1 2025 Portfolio in Review
As of Q1 2025, Zurich Cantonal Bank held 2,717 positions worth $34.8B, down 0.77% from $35.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Zurich Cantonal Bank deployed $1.37B of net new capital in Q1 2025, opening 60 new positions and adding to 1,190 existing holdings. Its largest new stake was Sandisk: 28,616 shares worth $1.36M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Hubbell, an estimated $71M trimmed.
- Zurich Cantonal Bank's largest Q1 2025 buy was Sandisk: 28,616 shares worth $1.36M.
- Zurich Cantonal Bank added most to UBS Group in Q1 2025, an estimated $140M increase.
- Zurich Cantonal Bank's biggest Q1 2025 reduction was Hubbell, cutting an estimated $71M.
- Zurich Cantonal Bank fully exited Zebra Technologies in Q1 2025, selling an estimated $4.55M.
- Zurich Cantonal Bank's ten largest holdings make up 32% of its $34.8B portfolio in Q1 2025.
- Zurich Cantonal Bank opened 60 new positions and closed 91 in Q1 2025.
- Zurich Cantonal Bank's portfolio value fell 0.77% quarter-over-quarter to $34.8B.
Based on Zurich Cantonal Bank's 13F filing for Q1 2025, filed 7 May 2025.